Reynders McVeigh Capital Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1455969 BOSTON, MA

Position in VRTX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$24,409,662

-$28,708 QoQ

Shares Held

54,664

+1.4% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Healthcare · as of Mar 31, 2026

Reynders McVeigh Capital Management, LLC holds $30,281,607 across 2 Biotechnology names. VRTX ranks #1 (80.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	54,664	$24,409,662
2	CRSP	CRISPR Therapeutics AG	123,438	$5,871,945

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,409,662	54,664	+1.4%	Shares	Sole	2026-04-27
2025-12-31	$24,438,370	53,905	-2.6%	Shares	Sole	2026-02-02
2025-09-30	$21,677,274	55,350	+1.9%	Shares	Sole	2025-11-17
2025-06-30	$24,178,812	54,310	+1.8%	Shares	Sole	2025-09-04
2025-03-31	$25,858,359	53,336	+2.1%	Shares	Sole	2025-05-12
2024-12-31	$21,042,685	52,254	+7.2%	Shares	Sole	2025-02-13
2024-09-30	$22,663,348	48,730	+14.8%	Shares	Sole	2024-11-14
2024-06-30	$19,902,319	42,461	+38.8%	Shares	Sole	2024-08-13
2024-03-31	$12,791,524	30,601	+89.6%	Shares	Sole	2024-05-07
2023-12-31	$6,567,611	16,141	+14.7%	Shares	Sole	2024-02-07
2023-09-30	$4,893,049	14,071	+50.0%	Shares	Sole	2023-11-09
2023-06-30	$3,301,619	9,382	+136.2%	Shares	Sole	2023-08-09
2023-03-31	$1,251,458	3,972	+178.7%	Shares	Sole	2023-05-03
2022-12-31	$411,511	1,425	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.